I
Isa Saúde
Hospital-at-home healthtech delivering diagnostics, infusions, rehab, and high-complexity care in Brazil
About Isa Saúde
Founded in 2017 by brothers Fernando and David Pares, ISA is a Brazilian healthtech company providing at-home healthcare services. The founders' background is rooted in the healthcare sector; their father founded the LEGO laboratory network, and David is a physician who worked at Hospital Albert Einstein for over seven years, while Fernando has prior entrepreneurial experience in the health industry.
The company operates with an asset-light business model, connecting patients with a network of independent nurses and phlebotomists for at-home services, which include diagnostic exams, COVID-19 tests, and vaccinations. This model aims to reduce costs by up to 50% compared to traditional laboratories by eliminating real estate and non-clinical expenses. Its logistics are optimized by using separate professionals for sample collection (nurses) and transportation ('bioconductors'), increasing the number of daily appointments a nurse can handle.
ISA primarily serves the B2B market, which accounts for 80% of its revenue, partnering with health insurance plans, hospitals, and corporate clients like iFood and BTG. The remaining 20% comes from direct-to-consumer services. In November 2022, ISA acquired Saúde C, a home healthcare startup, to expand its portfolio to include hospital-level care at home, such as administering IV drips. The company has raised significant funding, including a BRL 60 million round in August 2022 and an additional US$ 6 million in November 2022, from investors such as Fleury, Sabin, Vox Capital, and the family that controls Rede D'Or.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Aug 2022 | $11M | $43M | FIR Capital · Sabin Laboratory · Kortex Ventures · Yaya Capital | ↗ |
| SEEDOther financing | Sep 2021 | $3M | $12M | MatterScale Ventures · Canary · Norte Ventures · Albert Einstein Hospital São Paulo | — |
Growth signals
Latest recorded traffic for Isa Saúde is 15K monthly website visits, up 0% over the last three months. Isa Saúde's team grew 16.1% over the past year.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
MatterScale VenturesCanary
Norte Ventures
Albert Einstein Hospital São Paulo
Series B and later8 investors entered at this stage
FIR Capital
Sabin Laboratory
Kortex Ventures
Yaya Capital
Bradesco Saúde
Vox Capital
ScaleUP Ventures
Moll family office
Other known investors1 additional known investor
Endeavor ScaleUp Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Isa Saúde on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Isa Saúde’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.